Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 928643, 6 pages
http://dx.doi.org/10.1155/2012/928643
Research Article

Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease

1Department of Pharmacology, School of Pharmacy, Jilin University, Changchun 130021, China
2Institute of Changbai Mountain Natural Resources, Jilin Academy of Chinese Medicine Sciences, Changchun 130012, China
3College of Pharmacy, Yanbian University, Yanji 133002, China

Received 17 September 2011; Revised 5 November 2011; Accepted 7 November 2011

Academic Editor: Mahmud Tareq Hassan Khan

Copyright © 2012 Chuanfeng Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [38 citations]

The following is the list of published articles that have cited the current article.

  • Lucio G. Costa, Rian de Laat, Khoi Dao, Claudia Pellacani, Toby B. Cole, and Clement E. Furlong, “Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection,” NeuroToxicology, 2013. View at Publisher · View at Google Scholar
  • Christian Guerra-Araiza, Ana Laura Álvarez-Mejía, Stephanie Sánchez-Torres, Eunice Farfan-García, Rodrigo Mondragón-Lozano, Rodolfo Pinto-Almazán, and Hermelinda Salgado-Ceballos, “Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases,” Free Radical Research, vol. 47, no. 6-7, pp. 451–462, 2013. View at Publisher · View at Google Scholar
  • Lucio G. Costa, Leah Tait, Rian Laat, Khoi Dao, Gennaro Giordano, Claudia Pellacani, Toby B. Cole, and Clement E. Furlong, “Modulation of Paraoxonase 2 (PON2) in Mouse Brain by the Polyphenol Quercetin: A Mechanism of Neuroprotection?,” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  • S.S. Karuppagounder, S.K. Madathil, M. Pandey, R. Haobam, U. Rajamma, and K.P. Mohanakumar, “Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats,” Neuroscience, vol. 236, pp. 136–148, 2013. View at Publisher · View at Google Scholar
  • Khushwant S. Bhullar, and H. P. Vasantha Rupasinghe, “Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases,” Oxidative Medicine and Cellular Longevity, vol. 2013, pp. 1–18, 2013. View at Publisher · View at Google Scholar
  • Weidong Pan, Shin Kwak, Guoyan Li, Yiyun Chen, and Dingfang Cai, “Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease,” Chinese Medicine, vol. 8, no. 1, pp. 14, 2013. View at Publisher · View at Google Scholar
  • Cristian Sandoval-Acuña, Jorge Ferreira, and Hernán Speisky, “Polyphenols and mitochondria: An update on their increasingly emerging ROS-scavenging independent actions,” Archives of Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  • Yurong Hou, Yan Zeng, Sifan Li, Lei Qi, Wei Xu, Hong Wang, Xiujuan Zhao, and Changhao Sun, “Effect of quercetin against dichlorvos induced nephrotoxicity in rats,” Experimental and Toxicologic Pathology, 2014. View at Publisher · View at Google Scholar
  • Weidong Le, and Pavani Sayana, “Animal Models of Parkinson's Disease: A Gateway to Therapeutics?,” Neurotherapeutics, vol. 11, no. 1, pp. 92–110, 2014. View at Publisher · View at Google Scholar
  • Federico Dajas, Juan Andrés Abin-Carriquiry, Florencia Arredondo, Fernanda Blasina, Carolina Echeverry, Marcela Martínez, Felicia Rivera, and Lucía Vaamonde, “Quercetin in brain diseases: Potential and limits,” Neurochemistry International, 2015. View at Publisher · View at Google Scholar
  • Sonal Agrawal, Anubhuti Dixit, Ashish Singh, Pratibha Tripathi, Dhirendra Singh, Devendra Kumar Patel, and Mahendra Pratap Singh, “Cyclosporine A and MnTMPyP Alleviate alpha-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism,” Molecular Neurobiology, vol. 52, no. 3, pp. 1619–1628, 2015. View at Publisher · View at Google Scholar
  • Juan Segura-Aguilar, and Richard M. Kostrzewa, “Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update,” Neurotoxicity Research, 2015. View at Publisher · View at Google Scholar
  • Lsha Solanki, Priyanka Parihar, Mohammad Lukman Mansuri, and Mordhwaj S. Parihar, “Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases,” Advances in Nutrition, vol. 6, no. 1, pp. 64–72, 2015. View at Publisher · View at Google Scholar
  • Priyanka Parihar, Mordhwaj Singh Parihar, and Isha Solanki, “Neurodegenerative diseases: From available treatments to prospective herbal therapy,” Neurochemistry International, vol. 95, pp. 100–108, 2016. View at Publisher · View at Google Scholar
  • Natarajan Suganthy, Kasi Pandima Devi, Seyed Fazel Nabavi, Nady Braidy, and Seyed Mohammad Nabavi, “Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions,” Biomedicine & Pharmacotherapy, vol. 84, pp. 892–908, 2016. View at Publisher · View at Google Scholar
  • Elvira Ventura-Spagnolo, Gioacchino Calapai, Santa Cirmi, Nadia Ferlazzo, Giovanni E. Lombardo, Sebastiano Gangemi, and Michele Navarra, “Neurodegenerative diseases: Might citrus flavonoids play a protective role?,” Molecules, vol. 21, no. 10, 2016. View at Publisher · View at Google Scholar
  • Lucio G. Costa, Jacqueline M. Garrick, Pamela J. Roquè, and Claudia Pellacani, “Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More,” Oxidative Medicine and Cellular Longevity, vol. 2016, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Muhammet Ay, Adhithiya Charli, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, and Anumantha G. Kanthasamy, “Quercetin,” Nutraceuticals, pp. 447–452, 2016. View at Publisher · View at Google Scholar
  • Yujeong Lee, Min-Sun Kim, and Jaewon Lee, “Neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism,” Archives of Pharmacal Research, 2017. View at Publisher · View at Google Scholar
  • Inês Figueira, Regina Menezes, Diana Macedo, Inês Costa, and Cláudia Nunes dos Santos, “Polyphenols beyond barriers: A glimpse into the brain,” Current Neuropharmacology, vol. 15, no. 4, pp. 562–594, 2017. View at Publisher · View at Google Scholar
  • Muhammet Ay, Jie Luo, Monica Langley, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, and Anumantha G. Kanthasamy, “Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease,” Journal of Neurochemistry, 2017. View at Publisher · View at Google Scholar
  • Maciej Gawlik, Małgorzata B. Gawlik, Irena Smaga, and Małgorzata Filip, “Manganese neurotoxicity and protective effects of resveratrol and quercetin in preclinical research,” Pharmacological Reports, vol. 69, no. 2, pp. 322–330, 2017. View at Publisher · View at Google Scholar
  • Eshan Khan, Arpita tawani, Subodh Kumar Mishra, Arun Kumar Verma, Arun Upadhyay, Mohit Kumar, Rajat Sandhir, Amit Mishra, and Amit Kumar, “Myricetin reduces toxic level of CAG repeats RNA in Huntington’s Disease (HD) and Spino Cerebellar Ataxia (SCAs),” ACS Chemical Biology, 2017. View at Publisher · View at Google Scholar
  • S. Niveditha, T. Shivanandappa, and S.R Ramesh, “Ameliorative Potential of Natural Antioxidants Against Paraquat-Induced Oxidative Stress and Locomotor Impairment in Drosophila melanogaster: A Comparative Study,” The Open Bioactive Compounds Journal, vol. 5, no. 1, pp. 43–56, 2017. View at Publisher · View at Google Scholar
  • Adele Romano, Gaetano Serviddio, Silvio Calcagnini, Rosanna Villani, Anna Maria Giudetti, Tommaso Cassano, and Silvana Gaetani, “Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal,” Free Radical Biology and Medicine, 2017. View at Publisher · View at Google Scholar
  • Pamela Maher, “Protective effects of fisetin and other berry flavonoids in Parkinson's disease,” Food Funct., 2017. View at Publisher · View at Google Scholar
  • Bai-Yun Zeng, “Effect and Mechanism of Chinese Herbal Medicine on Parkinson's Disease,” 2017. View at Publisher · View at Google Scholar
  • Małgorzata Kujawska, and Jadwiga Jodynis-Liebert, “Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies,” Nutrients, vol. 10, no. 5, pp. 642, 2018. View at Publisher · View at Google Scholar
  • Ayse Ozkan, Gamze Tanriover, Aysel Agar, Hande Parlak, Sayra Dilmac, and Ozlem Ozsoy, “Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson’s disease,” Folia Histochemica et Cytobiologica, vol. 56, no. 1, pp. 27–37, 2018. View at Publisher · View at Google Scholar
  • Un Ju Jung, and Sang Ryong Kim, “Beneficial Effects of Flavonoids Against Parkinson's Disease,” Journal of Medicinal Food, 2018. View at Publisher · View at Google Scholar
  • Juan Carlos Corona, “Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder,” BioMed Research International, vol. 2018, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Latha Periyasamy, Phaniendra Alugoju, and Krishna Swamy, “Effect of short-term quercetin, caloric restriction and combined treatment on age-related oxidative stress markers in the rat cerebral cortex,” CNS and Neurological Disorders - Drug Targets, vol. 17, no. 2, pp. 119–131, 2018. View at Publisher · View at Google Scholar
  • Marc Morissette, Nadhir Litim, and Th?r?se Di Paolo, “Natural Phytoestrogens,” Discovery and Development of Neuroprotective Agents from Natural Products, pp. 9–61, 2018. View at Publisher · View at Google Scholar
  • Sara Thabit, Heba Handoussa, Mariana Roxo, Bruna Cestari de Azevedo, Nesrine S.E. El Sayed, and Michael Wink, “Styphnolobium japonicum (L.) Schott Fruits Increase Stress Resistance and Exert Antioxidant Properties in Caenorhabditis elegans and Mouse Models,” Molecules, vol. 24, no. 14, pp. 2633, 2019. View at Publisher · View at Google Scholar
  • Pamela Maher, “The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases,” International Journal of Molecular Sciences, vol. 20, no. 12, pp. 3056, 2019. View at Publisher · View at Google Scholar
  • Jun Shi, Siyi Guo, Yanting Wu, Guitian Chen, Jianhui Lai, and Xiaoqi Xu, “Behaviour of cell penetrating peptide TAT-modified liposomes loaded with salvianolic acid B on the migration, proliferation, and survival of human skin fibroblasts,” Journal of Liposome Research, pp. 1–14, 2019. View at Publisher · View at Google Scholar
  • Simranjeet Kaur, Neha Singla, and D. K. Dhawan, “Neuro-protective potential of quercetin during chlorpyrifos induced neurotoxicity in rats,” Drug and Chemical Toxicology, pp. 1–11, 2019. View at Publisher · View at Google Scholar
  • Jakaria, Azam, Jo, Kim, Dash, and Choi, “Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment,” Journal of Clinical Medicine, vol. 8, no. 11, pp. 1789, 2019. View at Publisher · View at Google Scholar